The effect of patient and contextual characteristics on racial/ethnic disparity in breast cancer mortality

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 7, 2016, Pages 1064-1072

  Sposto, Richard ^a,b   Keegan, Theresa H M ^c   Vigen, Cheryl ^a   Kwan, Marilyn L ^d   Bernstein, Leslie ^e   John, Esther M ^f,g,h   Cheng, Iona ^f,g   Yang, Juan ^f   Koo, Jocelyn ^f   Kurian, Allison W ^g,h   Caan, Bette J ^d   Lu, Yani ^e   Monroe, Kristine R ^a   Shariff Marco, Salma ^f,g,h   Gomez, Scarlett Lin ^f,g,h   Wu, Anna H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DIVISION OF RESEARCH   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f Cancer Prevention Institute of California   (United States)

^g STANFORD CANCER INSTITUTE   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; BODY SIZE; BREAST CANCER; CALIFORNIA; CANCER MORTALITY; CAUCASIAN; COMORBIDITY; ETHNIC DIFFERENCE; FEMALE; HEALTH DISPARITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; NEIGHBORHOOD; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RACE DIFFERENCE; SMOKING; SOCIAL STATUS; BREAST TUMOR; COHORT ANALYSIS; EPIDEMIOLOGY; ETHNOLOGY; EXERCISE; HEALTH CARE DISPARITY; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AFRICAN AMERICANS; ASIAN AMERICANS; BODY SIZE; BREAST NEOPLASMS; CALIFORNIA; COHORT STUDIES; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84977156644     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-1326     Document Type: Article

References (46)

1. Jatoi I, AndersonWF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol 2005;23:7836-41
2. Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer 2003;98:894-9
3. Menashe I, Anderson WF, Jatoi I, Rosenberg PS. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst 2009;101:993-1000
4. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 2008;112:171-80
5. McKenzie F, Jeffreys M. Do lifestyle or social factors explain ethnic/racial inequalities in breast cancer survival? Epidemiol Rev 2009;31:52-66
6. Nietert PJ, Sutherland SE, Keil JE, Bachman DL. Demographic and biologic influences on survival in whites and blacks: 40 years of follow-up in the Charleston Heart Study. Int J Equity Health 2006;5:8
7. Keegan TH, Kurian AW, Gali K, Tao L, Lichtensztajn DY, Hershman DL, et al. Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. Am J Public Health 2015;105:938-46
8. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 2003;81:21-31
9. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49-56
10. Wright JL, Reis IM, Zhao W, Panoff JE, Takita C, Sujoy V, et al. Racial disparity in estrogen receptor positive breast cancer patients receiving trimodality therapy. Breast 2012;21:276-83
11. Kurian AW, Lichtensztajn DY, Keegan TH, Leung RW, Shema SJ, Hershman DL, et al. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat 2013;137:247-60
12. Adams SA, Butler WM, Fulton J, Heiney SP, Williams EM, Delage AF, et al. Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast. Cancer 2012;118:2693-9
13. Smith ER, Adams SA, Das IP, Bottai M, Fulton J, Hebert JR. Breast cancer survival among economically disadvantaged women: the influences of delayed diagnosis and treatment on mortality. Cancer Epidemiol Biomarkers Prev 2008;17:2882-90
14. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, et al. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 2009;124:1213-9
15. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005;294:1765-72
16. Akinyemiju TF, Soliman AS, Johnson NJ, Altekruse SF, Welch K, Banerjee M, et al. Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities. J Cancer Epidemiol 2013;2013:490472
17. Bach PB, SchragD, Brawley OW,Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA 2002;287:2106-13
18. Shiao YH, Chen VW, Scheer WD, Wu XC, Correa P. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 1995;55:1485-90
19. Wang C, Civan J, Lai Y, Cristofanilli M, Hyslop T, Palazzo JP, et al. Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables. Cancer Causes Control 2015;26:45-56
20. Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, et al. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 2010;122:859-65
21. Yancik R, Wesley MN,Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001;285:885-92
22. Abrahamson PE, Gammon MD, Lund MJ, Flagg EW, Porter PL, Stevens J, et al. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1871-7
23. Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev 2007;16:1803-11
24. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 1990;16:205-14
25. Keegan TH, Milne RL, Andrulis IL, Chang ET, Sangaramoorthy M, Phillips KA, et al. Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry. Breast Cancer Res Treat 2010;123:531-42
26. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 2002;20:3302-16
27. West-Wright CN, Henderson KD, Sullivan-Halley J, Ursin G, Deapen D, Neuhausen S, et al. Long-term and recent recreational physical activity and survival after breast cancer: the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2009;18:2851-9
28. Sternfeld B, Weltzien E, Quesenberry CPJr, Castillo AL, Kwan M, Slattery ML, et al. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev 2009;18:87-95
29. Gomez SL, Glaser SL, McClure LA, Shema SJ, Kealey M, Keegan TH, et al. The California Neighborhoods Data System: a new resource for examining the impact of neighborhood characteristics on cancer incidence and outcomes in populations. Cancer Causes Control 2011;22:631-47
30. Brownson RC, Hoehner CM, Day K, Forsyth A, Sallis JF. Measuring the built environment for physical activity: state of the science. Am J Prev Med 2009;36:S99-123
31. Cheng I, Shariff-Marco S, Koo J, Monroe KR, Yang J, John EM, et al. Contribution of the neighborhood environment and obesity to breast cancer survival: the California Breast Cancer Survivorship Consortium. Cancer Epidemiol Biomarkers Prev 2015;24:1282-90
32. Shariff-Marco S, Yang J, John EM, Kurian AW, Cheng I, Leung R, et al. Intersection of race/ethnicity and socioeconomic status in mortality after breast cancer. J Community Health 2015;40:1287-99
33. Lu Y, John EM, Sullivan-Halley J, Vigen C, Gomez SL, Kwan ML, et al. History of recreational physical activity and survival after breast cancer: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 2015;181:944-55
34. KwanML, John EM, Caan BJ, Lee VS, Bernstein L, Cheng I, et al. Obesity and mortality after breast cancer by race/ethnicity: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 2014;179:95-111
35. Wu AH, Kurian AW, Kwan ML, John EM, Lu Y, Keegan TH, et al. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev 2015;24:361-8
36. Wu AH, Gomez SL, Vigen C, Kwan ML, Keegan TH, Lu Y, et al. The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control 2013;24:1821-36
37. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, et al. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat 2012;136:521-33
38. Pierce JP, Patterson RE, Senger CM, Flatt SW, Caan BJ, Natarajan L, et al. Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project. J Natl Cancer Inst 2014;106:djt359
39. Livaudais JC,HershmanDL, Habel L, Kushi L, Gomez SL, Li CI, et al. Racial/ ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat 2012;131:607-17
40. Sharma C, Harris L, Haffty BG, Yang Q, Moran MS. Does compliance with radiation therapy differ in African-American patients with early-stage breast cancer? Breast J 2010;16:193-6
41. Bhatta SS, Hou N, Moton ZN, Polite BN, Fleming GF, Olopade OI, et al. Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer. Springerplus 2013;2:356
42. Albain KS, Unger JM, Crowley JJ, Coltman CAJr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009;101:984-92
43. Shimizu T, Ochiai H, Asell F, Shimizu H, Saitoh R, Hama Y, et al. Bioinformatics research on inter-racial difference in drug metabolism. I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19. Drug Metab Pharmacokinet 2003;18:48-70
44. Lim JS, Chen XA, Singh O, Yap YS, Ng RC, Wong NS, et al. Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. Br J Clin Pharmacol 2011;71:737-50
45. Zeng Z, Liu Y, Liu Z, You J, Chen Z, Wang J, et al. CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: ametaanalysis. Cancer Chemother Pharmacol 2013;72:287-303
46. Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, Kwan ML, et al. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr 2012;96:123-32